Open-Label Phase III Long-Term Safety Trial of Liprotamase

Evaluation of Ivacaftor in Patients Using Ataluren for Nonsense Mutations

NCT03256799 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)

NCT00408317 ·Status: COMPLETED ·Phase: PHASE3

Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

NCT00775528 ·Status: COMPLETED ·Phase: PHASE3

Study of Ataluren (PTC124™) in Cystic Fibrosis

NCT00803205 ·Status: COMPLETED ·Phase: PHASE3

Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF)

NCT02139306 ·Status: COMPLETED ·Phase: PHASE3

PTC Study to Evaluate Ataluren in Combination With Ivacaftor

NCT03256968 ·Status: COMPLETED ·Phase: PHASE4

Short Term Safety and Efficacy of Lubiprostone in Adults With Cystic Fibrosis

NCT00706004 ·Status: COMPLETED ·Phase: NA

Proton Pump Inhibitors (PPI) and Fat Absorption in Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI)

NCT03551691 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)

NCT00513682 ·Status: COMPLETED ·Phase: PHASE3

Extension Study of Ataluren in Participants With Nonsense Mutation Cystic Fibrosis

NCT02456103 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

NCT02415959 ·Status: COMPLETED ·Phase: PHASE2

Control of Steatorrhea in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency

NCT01327703 ·Status: COMPLETED ·Phase: PHASE4

Study of Ataluren (PTC124) in Cystic Fibrosis

NCT02107859 ·Status: TERMINATED ·Phase: PHASE3

Safety Study of Fenretinide in Adult Patients With Cystic Fibrosis

NCT02141958 ·Status: COMPLETED ·Phase: PHASE1

Study of Pancreatic Enzyme Product in Pediatric Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency

NCT00981214 ·Status: COMPLETED ·Phase: PHASE3

Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

NCT00510484 ·Status: COMPLETED ·Phase: PHASE3

Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF)

NCT00690820 ·Status: COMPLETED ·Phase: PHASE3

A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ≥ 12 Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

NCT02137382 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than Four Years With Pancreatic Exocrine Insufficiency

NCT01747330 ·Status: COMPLETED ·Phase: PHASE3

Extension Study of Ataluren (PTC124) in Cystic Fibrosis

NCT01140451 ·Status: COMPLETED ·Phase: PHASE3

A Study of Ataluren in Pediatric Participants With Cystic Fibrosis

NCT00458341 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Mode of Administration and Safety of EUR-1008 (APT-1008) in Infants 1 to 12 Months of Age

NCT01100606 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess an Enteric Microgranule Formulation of Adrulipase in Patients With Cystic Fibrosis

NCT05719311 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess the Safety and PK of Oral and IV Xenleta in Adults With Cystic Fibrosis

NCT05225805 ·Status: COMPLETED ·Phase: PHASE1

Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy Study

NCT00446680 ·Status: COMPLETED ·Phase: PHASE3